TNBC 免疫治療再加一!美 FDA 核准 Keytruda 新適應症 基因線上 GeneOnline - 16 Nov 2020 TNBC 免疫治療再加一!美 FDA 核准 Keytruda 新適應症 ... More
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC etnet 經濟通 - 20 Aug 2024 Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC ... More
2022 ESMO:HER2 陽性早、晚期乳癌雙標靶組合增存活 基因線上 GeneOnline - 13 Sep 2022 2022 ESMO:HER2 陽性早、晚期乳癌雙標靶組合增存活 ... More